<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
    <channel>
        <title>TrialSiteNews Feed</title>
        <link>https://trialsitenews.com</link>
        <description>This is a feed of all latest posts on TrialSiteNews</description>
        <lastBuildDate>Fri, 03 Jul 2026 03:20:49 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>NextJS + feed package</generator>
        <language>en</language>
        <item>
            <title><![CDATA[Can Intensive Rehabilitation Change the Course of Mild Traumatic Brain Injury? New National Trial Aims to Find Out]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/can-intensive-rehabilitation-change-the-course-of-mild-traumatic-brain-injury-new-national-trial-aims-to-find-out-d3480b5d</link>
            <guid>https://trialsitenews.com/p/trialsitenews/can-intensive-rehabilitation-change-the-course-of-mild-traumatic-brain-injury-new-national-trial-aims-to-find-out-d3480b5d</guid>
            <pubDate>Thu, 02 Jul 2026 19:00:01 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/can-intensive-rehabilitation-change-the-course-of-mild-traumatic-brain-injury-new-national-trial-aims-to-find-out-d3480b5d" title="Can Intensive Rehabilitation Change the Course of Mild Traumatic Brain Injury? New National Trial Aims to Find Out" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/7b7364c0-a767-4df7-5a8d-0739cb553f00/public" loading="lazy" /></a> Can Intensive Rehabilitation Change the Course of Mild Traumatic Brain Injury? New National Trial Aims to Find Out]]></description>
        </item>
        <item>
            <title><![CDATA[CMS Bets Big on Digital Health: Will Medicare's ACCESS Model Deliver Outcomes—or Create a National Beta Test?]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/cms-bets-big-on-digital-health-will-medicares-access-model-deliver-outcomesor-create-a-national-beta-test-ad508510</link>
            <guid>https://trialsitenews.com/p/trialsitenews/cms-bets-big-on-digital-health-will-medicares-access-model-deliver-outcomesor-create-a-national-beta-test-ad508510</guid>
            <pubDate>Thu, 02 Jul 2026 18:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/cms-bets-big-on-digital-health-will-medicares-access-model-deliver-outcomesor-create-a-national-beta-test-ad508510" title="CMS Bets Big on Digital Health: Will Medicare's ACCESS Model Deliver Outcomes—or Create a National Beta Test?" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/cf9e1b98-bc88-4d04-7277-4a17d3d25700/public" loading="lazy" /></a> CMS Bets Big on Digital Health: Will Medicare's ACCESS Model Deliver Outcomes—or Create a National Beta Test?]]></description>
        </item>
        <item>
            <title><![CDATA[Iowa Becomes Sixth State to Allow Over-the-Counter Ivermectin Sales]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/iowa-becomes-sixth-state-to-allow-over-the-counter-ivermectin-sales-f4bc131c</link>
            <guid>https://trialsitenews.com/p/trialsitenews/iowa-becomes-sixth-state-to-allow-over-the-counter-ivermectin-sales-f4bc131c</guid>
            <pubDate>Thu, 02 Jul 2026 18:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/iowa-becomes-sixth-state-to-allow-over-the-counter-ivermectin-sales-f4bc131c" title="Iowa Becomes Sixth State to Allow Over-the-Counter Ivermectin Sales" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/70eec2fe-3993-40a3-3b05-e03b60185e00/public" loading="lazy" /></a> Iowa Becomes Sixth State to Allow Over-the-Counter Ivermectin Sales]]></description>
        </item>
        <item>
            <title><![CDATA[Beyond the Executive Order: Can Regenerative Agriculture Really Transform America's Health?]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/beyond-the-executive-order-can-regenerative-agriculture-really-transform-americas-health-8f6ff2fe</link>
            <guid>https://trialsitenews.com/p/trialsitenews/beyond-the-executive-order-can-regenerative-agriculture-really-transform-americas-health-8f6ff2fe</guid>
            <pubDate>Thu, 02 Jul 2026 17:16:40 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/beyond-the-executive-order-can-regenerative-agriculture-really-transform-americas-health-8f6ff2fe" title="Beyond the Executive Order: Can Regenerative Agriculture Really Transform America's Health?" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/6b74fd11-0d29-4ac2-e159-e5451e2e5200/public" loading="lazy" /></a> Beyond the Executive Order: Can Regenerative Agriculture Really Transform America's Health?]]></description>
        </item>
        <item>
            <title><![CDATA[Washington Examiner Op-Ed Warns RFK Jr.'s Vaccine Liability Agenda Could Threaten Future Cancer Innovation]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/washington-examiner-op-ed-warns-rfk-jr.s-vaccine-liability-agenda-could-threaten-future-cancer-innovation-dbc90cd1</link>
            <guid>https://trialsitenews.com/p/trialsitenews/washington-examiner-op-ed-warns-rfk-jr.s-vaccine-liability-agenda-could-threaten-future-cancer-innovation-dbc90cd1</guid>
            <pubDate>Thu, 02 Jul 2026 17:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/washington-examiner-op-ed-warns-rfk-jr.s-vaccine-liability-agenda-could-threaten-future-cancer-innovation-dbc90cd1" title="Washington Examiner Op-Ed Warns RFK Jr.'s Vaccine Liability Agenda Could Threaten Future Cancer Innovation" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/64abbb7b-018c-4639-a900-28702d83c800/public" loading="lazy" /></a> Washington Examiner Op-Ed Warns RFK Jr.'s Vaccine Liability Agenda Could Threaten Future Cancer Innovation]]></description>
        </item>
        <item>
            <title><![CDATA[Texas Agriculture Commissioner Seeks FDA Authorization for Feed-Based Ivermectin to Combat New World Screwworm]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/texas-agriculture-commissioner-seeks-fda-authorization-for-feed-based-ivermectin-to-combat-new-world-screwworm-3702f8b5</link>
            <guid>https://trialsitenews.com/p/trialsitenews/texas-agriculture-commissioner-seeks-fda-authorization-for-feed-based-ivermectin-to-combat-new-world-screwworm-3702f8b5</guid>
            <pubDate>Thu, 02 Jul 2026 16:00:01 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/texas-agriculture-commissioner-seeks-fda-authorization-for-feed-based-ivermectin-to-combat-new-world-screwworm-3702f8b5" title="Texas Agriculture Commissioner Seeks FDA Authorization for Feed-Based Ivermectin to Combat New World Screwworm" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/a3ac69e3-260b-4906-af29-48b5c09adf00/public" loading="lazy" /></a> Texas Agriculture Commissioner Seeks FDA Authorization for Feed-Based Ivermectin to Combat New World Screwworm]]></description>
        </item>
        <item>
            <title><![CDATA[Congress Examines Pfizer and Eli Lilly China Military Trial Sites: Where Ethics, National Security, and Global Drug Development Converge]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/congress-examines-pfizer-and-eli-lilly-china-military-trial-sites-where-ethics-national-security-and-global-drug-development-converge-93a40315</link>
            <guid>https://trialsitenews.com/p/trialsitenews/congress-examines-pfizer-and-eli-lilly-china-military-trial-sites-where-ethics-national-security-and-global-drug-development-converge-93a40315</guid>
            <pubDate>Thu, 02 Jul 2026 15:00:01 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/congress-examines-pfizer-and-eli-lilly-china-military-trial-sites-where-ethics-national-security-and-global-drug-development-converge-93a40315" title="Congress Examines Pfizer and Eli Lilly China Military Trial Sites: Where Ethics, National Security, and Global Drug Development Converge" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/18c086f4-01e4-466f-89a7-588752797500/public" loading="lazy" /></a> Congress Examines Pfizer and Eli Lilly China Military Trial Sites: Where Ethics, National Security, and Global Drug Development Converge]]></description>
        </item>
        <item>
            <title><![CDATA[Next-Generation HIF-2? Inhibitor Delivers Durable Responses—and a Powerful Biomarker Signal—in Advanced Kidney Cancer]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/next-generation-hif-2-inhibitor-delivers-durable-responsesand-a-powerful-biomarker-signalin-advanced-kidney-cancer-cfe60771</link>
            <guid>https://trialsitenews.com/p/trialsitenews/next-generation-hif-2-inhibitor-delivers-durable-responsesand-a-powerful-biomarker-signalin-advanced-kidney-cancer-cfe60771</guid>
            <pubDate>Thu, 02 Jul 2026 14:30:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/next-generation-hif-2-inhibitor-delivers-durable-responsesand-a-powerful-biomarker-signalin-advanced-kidney-cancer-cfe60771" title="Next-Generation HIF-2? Inhibitor Delivers Durable Responses—and a Powerful Biomarker Signal—in Advanced Kidney Cancer" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/352c4739-d012-49d7-fcc5-2b021a0f3b00/public" loading="lazy" /></a> Next-Generation HIF-2? Inhibitor Delivers Durable Responses—and a Powerful Biomarker Signal—in Advanced Kidney Cancer]]></description>
        </item>
        <item>
            <title><![CDATA[Billions of Doses Later: The Lancet Reviews the mRNA Vaccine Era—How Convincing Is the Evidence?]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/billions-of-doses-later-the-lancet-reviews-the-mrna-vaccine-erahow-convincing-is-the-evidence-a55dbaed</link>
            <guid>https://trialsitenews.com/p/trialsitenews/billions-of-doses-later-the-lancet-reviews-the-mrna-vaccine-erahow-convincing-is-the-evidence-a55dbaed</guid>
            <pubDate>Thu, 02 Jul 2026 13:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/billions-of-doses-later-the-lancet-reviews-the-mrna-vaccine-erahow-convincing-is-the-evidence-a55dbaed" title="Billions of Doses Later: The Lancet Reviews the mRNA Vaccine Era—How Convincing Is the Evidence?" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/a3f8786a-3741-494e-2d98-3ee2fe539900/public" loading="lazy" /></a> Billions of Doses Later: The Lancet Reviews the mRNA Vaccine Era—How Convincing Is the Evidence?]]></description>
        </item>
        <item>
            <title><![CDATA[At The FDA Peptide Crossroads--Beyond Ban or Gray Market Lies The Third Path—Real-World Evidence]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/at-the-fda-peptide-crossroads-beyond-ban-or-gray-market-lies-the-third-pathreal-world-evidence-aa4193f1</link>
            <guid>https://trialsitenews.com/p/trialsitenews/at-the-fda-peptide-crossroads-beyond-ban-or-gray-market-lies-the-third-pathreal-world-evidence-aa4193f1</guid>
            <pubDate>Thu, 02 Jul 2026 01:59:12 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/at-the-fda-peptide-crossroads-beyond-ban-or-gray-market-lies-the-third-pathreal-world-evidence-aa4193f1" title="At The FDA Peptide Crossroads--Beyond Ban or Gray Market Lies The Third Path—Real-World Evidence" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/5c1b7e27-0a28-4c11-d59c-00e719e50f00/public" loading="lazy" /></a> At The FDA Peptide Crossroads--Beyond Ban or Gray Market Lies The Third Path—Real-World Evidence]]></description>
        </item>
    </channel>
</rss>